Intellect Neurosciences Files New Patent Applications for Immunotherapy Methods to Target Abnormal Tau Protein in Treatment of Alzheimer’s Disease Intellect Neurosciences, Inc. announced that it has filed two United States and one international patent application regarding passive and active immunotherapy approaches targeting abnormal forms of tau protein that lead to death of nerve cells in Alzheimer’s disease. [Intellect Neuroscience, Inc.] Press Release University of California San Diego Moores Cancer Center Offers New Hope for Deadly Brain Tumor In the United States, each year, approximately 10,000 patients are affected by glioblastoma multiforme. Now, a novel investigational device is offering new hope to these patients. [University of California, San Diego] Press Release Administration Announces New Steps to Fight Alzheimer’s Disease The Obama Administration announced new efforts to fight Alzheimer’s disease, including immediately making an additional $50 million available for cutting-edge Alzheimer’s research. [United States Department of Health and Human Services] Press Release $30M Gift to Fast-Forward Health Care Research, Education and Care at McMaster University A Hamilton family is giving McMaster University $30 million to accelerate the university’s innovations in health research, education and care. [McMaster University] Press Release |